Navigation Links
Update: HYSTA Announces Dr. Qi Lu to Continue on as President of HYSTA, USA
Date:9/26/2008

SAN JOSE, Calif., Sept. 26 /PRNewswire/ -- Dr. Qi Lu, former EVP of Yahoo!, continues to dedicate his passion to the Chinese professional community and serve as the president of HYSTA, USA. HYSTA is greatly honored to have Qi's on-going commitment as President.

Qi officially left Yahoo! at end of August, he had served more than 10 years, which was a big change for him both personally and professionally, but one thing that has not changed is his dedication to serve the Chinese community and contribute to furthering HYSTA's vision in the role of President HYSTA, USA.

Said Qi Lu, "While I have left Yahoo, they still have my support. I greatly appreciate the many years I worked with such a world class organization. I'm looking forward to a new direction for myself in business and to continue to champion HYSTA's mission to help its members, serve the community and positively impact business between China and the Silicon Valley."

HYSTA will be presenting its annual conference -- China Beyond the Olympics on Saturday, October 4, 2008 at Santa Clara Convention Center. Renowned for its top industry business professional speakers and interactive panel discussions, HYSTA's past annual conference has attracted keynote speakers such as former Vice President Al Gore.

"I know of no greater business forum in the Silicon Valley, the sheer amount of experience, technical skill and networking opportunity is unsurpassed. My number one priority with HYSTA is to have this year's annual conference set a new standard of excellence in forums for business executives, venture capitalists and entrepreneurs interested in international opportunities."

About HYSTA:

HYSTA (Hua Yuan Science and Technology Association) is a leading Chinese professional association in the US. Founded in 1999 by a group of successful Chinese entrepreneurs, HYSTA aims at nurturing entrepreneurship and career development among Chinese technology and business professionals
'/>"/>

SOURCE HYSTA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
2. RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
3. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
4. HYSTA Announces Dr. Qi Lu to continue on as President of HYSTA, USA
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  Prima Biomed Ltd. (NASDAQ: PBMD ) ... become a leader in the development of immunotherapeutic products ... final CVac data from the Phase II CAN-003 ovarian ... a clinically meaningful improvement in Overall Survival ("OS") over ... In the group of second remission patients (n=20), ...
(Date:5/21/2015)... , May 21, 2015 ... inner feelings - and those of others. Being able ... senses. Analyze and read people to anticipate their thoughts ... your deepest emotions and feelings to create unique abstract ... of responsive games. Get inside a first-person-shooter as it ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... June 17 Schering-Plough,Corporation (NYSE: SGP ) is ... 2008 second quarter on Monday, July 21, 2008., ... conduct a conference,call to review results for the 2008 ... members of management will,host the conference call., To ...
... 17 Mergent, Inc., administrator for the,HealthShares(TM) Indexes, ... Exchange Traded Funds, today announced the quarterly,rebalancing of ... and,deleted in the Indexes effective before the opening ... HealthShares(TM) Autoimmune-Inflammation Index (HHA), Drop, ...
... NEW HAVEN, Conn., June 17 BioXcel ... ASDO Consulting Group,(ASDO), a leading consulting company ... global business analytics company, will combine forces ... of,services. These include business analytics to support,licensing/due-diligence, ...
Cached Biology Technology:Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings 2Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 16Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 17Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 18Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 19Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 20Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 21Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 22Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 23Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 24Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 25Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 26Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 27Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 28Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 29Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 30Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 31Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 32Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 33BioXcel Expands Its Capability in Business Analytics Support Services 2
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... a large epidemiologic study, researchers at UCLA,s Jonsson Cancer ... are at higher risk of having retinoblastoma, a malignant ... under six. The study, which focused on babies ... fathers were at greater risk for retinoblastoma, as were ...
... can encounter a host of health complications. The added weight ... at least initially. In a new study published in ... a University of Iowa researcher compared the weight and height ... born to normal-weight mothers. Contrary to expectations, babies ...
... -- A commercial vaccine for cattle can effectively reduce levels ... a Kansas State University study has found. The vaccine is ... doses, which can help cut costs for the beef industry. ... investigator on a project that researched the effectiveness of products ...
Cached Biology News:US-born Latinas at great risk of having babies with retinoblastoma 2Infants of overweight mothers grow more slowly 2Infants of overweight mothers grow more slowly 3A new line of defense: Researchers find cattle vaccine works to reduce E. coli O157:H7 2
... cultured in DMEM with 4 mM L-glutamine medium ... In order to keep the antigens in ... The cells are arrayed on a 12-well ... surface specifically treated to enhance cellular attachment and ...
... DMEM and harvested at the log phase of ... in their native forms, cells were fixed in ... 12-well (5 mm) adhesive coated slide, with each ... and to minimize background staining. Each well ...
... in DMEM and harvested at the log phase ... antigens in their native forms, cells were fixed ... a 12-well (5 mm) adhesive coated slide, with ... attachment and to minimize background staining. Each ...
...
Biology Products: